Aytu Bioscience, Inc. (AYTU) is having an incredibly strong day in the market today as it seems as though investors are finally starting to realize the potential opportunity here. Before we get into the details here we’d like to give a quick thank you to our friends at Trade Ideas for always being the first to alert us to gains. Currently (2:11), AYTU is trading at $4.45 per share after a gain of $0.45 per share or 11.25% thus far today.
Recent News Out Of AYTU
The most recent news that we’ve seen from Aytu Bioscience was that the company had signed an agreement with Mitsuboshi Product Planning, a company that specializes in marketing sexual dysfunction treatments. Under the agreement, Mitsuboshi will be in charge of commercialization of Fiera, claiming the position as the first international distributor of the treatment. In their announcement last week, AYTU said that it is expecting to announce additional international distribution agreements with regard to Fiera in the future. In a statement, Josh Disbrow, CEO at AYTU, had the following to offer:
“We are very pleased to have partnered with Mitsuboshi in Japan to make Fiera available for the many women that experience low sexual desire and may benefit from an innovative, non-drug product like Fiera… Japan is a large and growing sexual wellness market, and we believe that Mitsuboshi is very well positioned to establish Fiera as an important female sexual wellness brand among both clinicians and consumers throughout Japan.”
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
What We’ll Be Watching For Ahead
Moving forward, the CNA Finance team will continue to keep a close eye on AYTU. In particular, we’ll be watching the ongoing work to bring Fiera to the Japanese market. We’re also interested in following the ongoing growth of Natesto and the rest of the robust pipeline at Aytu Bioscience. Nonetheless, we’ll continue to follow the story closely and bring the news to you as it breaks!
Never Miss The News Again
Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!